Genomes and Genes

Species

Philip H Kim

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. pmc The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Philip H Kim
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    World J Urol 32:453-9. 2014
  2. doi request reprint Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis
    Philip H Kim
    Urology Service, Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York 10065, USA
    J Urol 189:602-8. 2013
  3. pmc Genomic Characterization of Upper Tract Urothelial Carcinoma
    John P Sfakianos
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    Eur Urol 68:970-7. 2015
  4. doi request reprint Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance
    Christopher B Anderson
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    J Urol 194:1607-11. 2015
  5. pmc Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy
    Philip H Kim
    Department of Surgery, Urology Service, New York, NY, USA
    BJU Int 114:354-9. 2014
  6. pmc Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma
    A Ari Hakimi
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York Electronic address
    J Urol 192:24-9. 2014
  7. doi request reprint Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance
    Sung Kyu Hong
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea Electronic address
    Eur Urol 66:214-9. 2014
  8. doi request reprint Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer
    John E Musser
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Electronic address
    J Urol 193:48-52. 2015
  9. pmc Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
    Philip H Kim
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Eur Urol 67:198-201. 2015
  10. pmc The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder
    John P Sfakianos
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY
    Urol Oncol 32:657-62. 2014

Collaborators

  • Karim Touijer
  • Hebert Alberto Vargas
  • Paul Russo
  • Jaspreet S Sandhu
  • Christopher B Anderson
  • John P Sfakianos
  • A Ari Hakimi
  • John E Musser
  • Bernard H Bochner
  • Victor E Reuter
  • Irina Ostrovnaya
  • Sung Kyu Hong
  • Dean F Bajorin
  • Emily C Zabor
  • David B Solit
  • Guido Dalbagni
  • Hikmat A Al-Ahmadie
  • Nikolaus Schultz
  • Qinghu Ren
  • Aphrothiti J Hanrahan
  • Neil B Desai
  • Aditya Bagrodia
  • Matthew J O'Shaughnessy
  • Arony Sun
  • Sasinya N Scott
  • Ricardo Ramirez
  • Michael F Berger
  • Ronak H Shah
  • Jonathan E Rosenberg
  • Jonathan A Coleman
  • Patrizia Pinciroli
  • Gopa Iyer
  • Harry W Herr
  • Eugene K Cha
  • Giovanni Ciriello
  • James A Eastham
  • Gal E Keren Paz
  • Hikmat Al-Ahmadie
  • Robert J Motzer
  • Peter T Scardino
  • Nina Mikkilineni
  • Itay A Sternberg
  • Geoffrey T Gotto
  • Roy Mano
  • James J Hsieh
  • Mithat Gonen
  • Lan Lin Gellert
  • Alexandra Maschino

Detail Information

Publications10

  1. pmc The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer
    Philip H Kim
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    World J Urol 32:453-9. 2014
    ..We investigated smoking as a potential predictor for pathologic outcomes after neoadjuvant chemotherapy (NC) and radical cystectomy (RC) for muscle-invasive bladder cancer...
  2. doi request reprint Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis
    Philip H Kim
    Urology Service, Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York 10065, USA
    J Urol 189:602-8. 2013
    ..Urinary incontinence is a frequent complication of radical prostatectomy with a detrimental impact on quality of life. We identified predictors and trends in the use of procedures for post-prostatectomy incontinence...
  3. pmc Genomic Characterization of Upper Tract Urothelial Carcinoma
    John P Sfakianos
    Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
    Eur Urol 68:970-7. 2015
    ..Despite a similar histologic appearance, upper tract urothelial carcinoma (UTUC) and urothelial carcinoma of the bladder (UCB) tumors have distinct epidemiologic and clinicopathologic differences...
  4. doi request reprint Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance
    Christopher B Anderson
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
    J Urol 194:1607-11. 2015
    ..We hypothesized that older age is associated with an increased risk of Gleason score upgrading at confirmatory biopsy when controlling for prostate volume...
  5. pmc Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in patients with bladder cancer with negative surveillance cystoscopy
    Philip H Kim
    Department of Surgery, Urology Service, New York, NY, USA
    BJU Int 114:354-9. 2014
    ..To assess the ability of reflex UroVysion fluorescence in situ hybridization (FISH) testing to predict recurrence and progression in patients with non-muscle-invasive bladder cancer (NMIBC) with suspicious cytology but negative cystoscopy...
  6. pmc Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma
    A Ari Hakimi
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York Electronic address
    J Urol 192:24-9. 2014
    ....
  7. doi request reprint Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance
    Sung Kyu Hong
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea Electronic address
    Eur Urol 66:214-9. 2014
    ..Limited data are currently available regarding the outcomes of radical prostatectomy (RP) in men with low-risk prostate cancer who were initially managed by active surveillance (AS)...
  8. doi request reprint Bladder biopsy of normal-appearing mucosa is not helpful in patients with unexplained positive cytology after nonmuscle invasive bladder cancer
    John E Musser
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York Electronic address
    J Urol 193:48-52. 2015
    ..Bladder biopsy is often advised but its efficacy is unclear. We evaluated the usefulness of bladder biopsy in patients with unexplained positive cytology and describe recurrence patterns in this unique patient subset...
  9. pmc Genomic predictors of survival in patients with high-grade urothelial carcinoma of the bladder
    Philip H Kim
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Eur Urol 67:198-201. 2015
    ..Genomic profiling may aid in the identification of UCB patients at highest risk following RC...
  10. pmc The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder
    John P Sfakianos
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY
    Urol Oncol 32:657-62. 2014
    ..Our goal was to understand whether PI3K/Akt pathway alterations associated with CIS resemble early- or late-stage bladder cancers...